search
Back to results

Breathe: Slow Paced Breathing to Lower Blood Pressure

Primary Purpose

High Blood Pressure

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Guided Breathing
RESPeRATE
Sponsored by
National Institute on Aging (NIA)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for High Blood Pressure focused on measuring hypertension, high blood pressure, meditation

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Over 21 years Systolic blood pressure 130-160 or diastolic blood pressure 85-100 Exclusion Criteria: More than one antihypertensive medication Beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers History of coronary artery disease, heart failure, stroke, angina or coronary revascularization Kidney disease, defined as plasma creatinine > 1.5mg/dL Diabetes, defined by insulin or oral hypoglycemic medication or blood sugar > 126mg/dL Pulmonary disease, defined as chronic obstructive pulmonary disease, bronchitis, asthma, or use of inhaler Upper respiratory infection during past 30 days Medication that affects central nervous system function Steroid use Current pregnancy or lactation within past six months Current birth control medication or hormone replacement therapy Condition that in the judgment of the Principal Investigator is incompatible with the research study

Sites / Locations

  • NIA Clinical Research Unit

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Device Guided Breathing

Control Group

Arm Description

Individual breathing rate was determined from an expandable band around the torso connected to a commercially available device (RESPeRATE, Lod, Israel) that presented distinctive tones via earphones.

Control group were instructed to sit in the same manner passively attend to their breathing, and silently repeat 'one' during each exhalation. If other thoughts came to mind, they were instructed to calmly attend to their breathing.

Outcomes

Primary Outcome Measures

Breathing Rate
Breathing rate was monitored continuously via inductive plethysmography.

Secondary Outcome Measures

Minute Ventilation
Minute Ventilation was continuously monitored via inductive plethysmography
End Tidal CO2 (PetCO2)
End tidal CO2 was monitored continuously using a respiratory gas monitor

Full Information

First Posted
May 18, 2006
Last Updated
June 5, 2017
Sponsor
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00328016
Brief Title
Breathe: Slow Paced Breathing to Lower Blood Pressure
Official Title
Respiratory Adaptations to Behavioral Interventions in Elevated Blood Pressure
Study Type
Interventional

2. Study Status

Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
April 2006 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Institute on Aging (NIA)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the nature of the physiological reasons for the decreases in resting blood pressure that can result from systematic practice of computer-guided breathing exercises or meditative relaxation.
Detailed Description
In this randomized clinical trial, persons with moderately elevated blood pressure were trained in either computer-guided breathing exercises or meditative relaxation to breathing. The computer-guided breathing exercise involves listening to tones of ascending and descending pitch to which breathing is entrained to low frequencies over a 15 minute interval. The meditative relaxation involves passive attention to natural breathing for the same duration. Participants will perform these breathing exercises daily at home for four weeks. Before and after the intervention, respiratory, cardiovascular, and urinary endogenous digitalis-like factors will be systematically recorded to determine the extent to which chronic neuroendocrine changes underlie the reductions in blood pressure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
High Blood Pressure
Keywords
hypertension, high blood pressure, meditation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
44 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Device Guided Breathing
Arm Type
Experimental
Arm Description
Individual breathing rate was determined from an expandable band around the torso connected to a commercially available device (RESPeRATE, Lod, Israel) that presented distinctive tones via earphones.
Arm Title
Control Group
Arm Type
Placebo Comparator
Arm Description
Control group were instructed to sit in the same manner passively attend to their breathing, and silently repeat 'one' during each exhalation. If other thoughts came to mind, they were instructed to calmly attend to their breathing.
Intervention Type
Behavioral
Intervention Name(s)
Guided Breathing
Intervention Description
The participant will engage in daily 15 min sessions of meditative relaxation that involves quiet attention to breathing pattern with no attempt to manipulate breathing pattern
Intervention Type
Device
Intervention Name(s)
RESPeRATE
Intervention Description
The participant will be trained to perform a guided breathing task that involves a chest expansion sensor, battery-powered microcomputer, and earphones
Primary Outcome Measure Information:
Title
Breathing Rate
Description
Breathing rate was monitored continuously via inductive plethysmography.
Time Frame
After 15 minutes of guided breathing or control task
Secondary Outcome Measure Information:
Title
Minute Ventilation
Description
Minute Ventilation was continuously monitored via inductive plethysmography
Time Frame
After 15 minutes of guided breathing or control task
Title
End Tidal CO2 (PetCO2)
Description
End tidal CO2 was monitored continuously using a respiratory gas monitor
Time Frame
After 15 minutes of guided breathing or control task

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Over 21 years Systolic blood pressure 130-160 or diastolic blood pressure 85-100 Exclusion Criteria: More than one antihypertensive medication Beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers History of coronary artery disease, heart failure, stroke, angina or coronary revascularization Kidney disease, defined as plasma creatinine > 1.5mg/dL Diabetes, defined by insulin or oral hypoglycemic medication or blood sugar > 126mg/dL Pulmonary disease, defined as chronic obstructive pulmonary disease, bronchitis, asthma, or use of inhaler Upper respiratory infection during past 30 days Medication that affects central nervous system function Steroid use Current pregnancy or lactation within past six months Current birth control medication or hormone replacement therapy Condition that in the judgment of the Principal Investigator is incompatible with the research study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William B. Ershler, M.D.
Organizational Affiliation
NIA, Clinical research Unit
Official's Role
Principal Investigator
Facility Information:
Facility Name
NIA Clinical Research Unit
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21225
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to share individual level data.
Citations:
PubMed Identifier
15062893
Citation
Meles E, Giannattasio C, Failla M, Gentile G, Capra A, Mancia G. Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens. 2004 Apr;17(4):370-4. doi: 10.1016/j.amjhyper.2003.12.009.
Results Reference
background
PubMed Identifier
15470284
Citation
Elliot WJ, Izzo JL Jr, White WB, Rosing DR, Snyder CS, Alter A, Gavish B, Black HR. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens (Greenwich). 2004 Oct;6(10):553-9; quiz 560-1. doi: 10.1111/j.1524-6175.2004.03553.x.
Results Reference
background
PubMed Identifier
11319675
Citation
Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Breathing-control lowers blood pressure. J Hum Hypertens. 2001 Apr;15(4):263-9. doi: 10.1038/sj.jhh.1001147.
Results Reference
background
Citation
Benson H. The Relaxation Response. New York: Avon Books, 1975
Results Reference
background
PubMed Identifier
18820654
Citation
Anderson DE, McNeely JD, Chesney MA, Windham BG. Breathing variability at rest is positively associated with 24-h blood pressure level. Am J Hypertens. 2008 Dec;21(12):1324-9. doi: 10.1038/ajh.2008.292. Epub 2008 Sep 25.
Results Reference
result
PubMed Identifier
20200548
Citation
Anderson DE, McNeely JD, Windham BG. Regular slow-breathing exercise effects on blood pressure and breathing patterns at rest. J Hum Hypertens. 2010 Dec;24(12):807-13. doi: 10.1038/jhh.2010.18. Epub 2010 Mar 4.
Results Reference
derived

Learn more about this trial

Breathe: Slow Paced Breathing to Lower Blood Pressure

We'll reach out to this number within 24 hrs